ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Vivoryon Therapeut

Vivoryon Therapeut (05Y)

1,968
0,00
(0,00%)
Geschlossen 27 Dezember 10:00PM
Echtzeitdaten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
1,968
Gebot
1,944
Fragen
1,992
Volumen
28.501
1,912 Tagesbereich 2,01
0,4205 52-Wochen-Bereich 9,99
Marktkapitalisierung
Handelsende
1,968
Handelsbeginn
1,992
Letzte Trade
245
@
1.988
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
47.514
Ausgegebene Aktien
26.066.808
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
-3,62M
Nettogewinn
-28,34M

Über Vivoryon Therapeut

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Halle, Deu
Gegründet
-
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker 05Y. The last closing price for Vivoryon Therapeut was 1,97 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0,4205 € to 9,99 €.

Vivoryon Therapeut currently has 26.066.808 shares in issue. The market capitalisation of Vivoryon Therapeut is 51,30 € million.

05Y Neueste Nachrichten

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function Vivoryon Therapeutics N.V. Presents Topline Phase...

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress...

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of...

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon...

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event Halle (Saale) / Munich, Germany, October 1, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Vivoryon Therapeutics N.V...

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and...

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024 Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial...

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in...

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0462.393340270551.9222.0351.88312621.98950964DE
4-0.077-3.765281173592.0452.7551.582635922.12604748DE
12-0.387-16.43312101912.3553.0451.582475142.28832494DE
260.0060.3058103975541.9623.0451.324404132.24099569DE
52-6.472-76.6824644558.449.990.4205982881.63933546DE
156-17.032-89.64210526321919.620.4205615361.84179362DE
260-12.65-86.537145984414.61822.850.4205436372.36661775DE

05Y - Frequently Asked Questions (FAQ)

What is the current Vivoryon Therapeut share price?
The current share price of Vivoryon Therapeut is 1,968 €
How many Vivoryon Therapeut shares are in issue?
Vivoryon Therapeut has 26.066.808 shares in issue
What is the market cap of Vivoryon Therapeut?
The market capitalisation of Vivoryon Therapeut is EUR 51,3M
What is the 1 year trading range for Vivoryon Therapeut share price?
Vivoryon Therapeut has traded in the range of 0,4205 € to 9,99 € during the past year
What is the reporting currency for Vivoryon Therapeut?
Vivoryon Therapeut reports financial results in EUR
What is the latest annual turnover for Vivoryon Therapeut?
The latest annual turnover of Vivoryon Therapeut is EUR -3,62M
What is the latest annual profit for Vivoryon Therapeut?
The latest annual profit of Vivoryon Therapeut is EUR -28,34M
What is the registered address of Vivoryon Therapeut?
The registered address for Vivoryon Therapeut is WEINBERGWEG 22, HALLE, 06120
What is the Vivoryon Therapeut website address?
The website address for Vivoryon Therapeut is www.vivoryon.com
Which industry sector does Vivoryon Therapeut operate in?
Vivoryon Therapeut operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
0RARAPT Therapeutics Inc
1,61 €
(101,25%)
83,81k
KASHIntellabridge Technology Corp
0,047 €
(88,00%)
1,24M
4APApollo Minerals Ltd
0,01 €
(66,67%)
30
AWY0Percheron Therapeutics Ltd
0,007 €
(55,56%)
660k
1W81WISeKey International Holding Ltd
9,70 €
(44,78%)
4,81k
013CJDcom Inc
17,426 €
(0,00%)
0
013AJD.com Inc
34,90 €
(0,00%)
0
0110Thesis Gold Inc
0,391 €
(0,00%)
0
00WAspermont Ltd
0,004 €
(0,00%)
0
000Greenvolt Energias Renovaveis SA
0,00 €
(0,00%)
0
D7GNel ASA
0,2496 €
(-0,79%)
3,89M
RQ0DWave Quantum Inc
7,896 €
(24,07%)
2,16M
FWR0Yumy Candy Company Inc the
0,0352 €
(40,80%)
2,12M
PF8European Lithium Limited
0,0204 €
(-0,97%)
2,07M
DI6Distribuidora Internacional De Alimentacion SA
0,017 €
(1,80%)
1,83M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock